Locations:
Search
An old drug shows new promise for a rare childhood cancer
Will we see this major breakthrough in 2019?
Objective risk assessment guides surveillance and treatment
Modified screening approach produces high detection rate
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Careful management of adverse intraoperative events may reduce morbidity and mortality
Advanced radiotherapy in a rare soft-tissue sarcoma
Experience to date highlights need for immunotherapy focus
What's driving tumor progression is the key, says Nima Sharifi, MD
Patients use fewer narcotics than anticipated
Staged reconstruction allows for easier reintervention if needed
Advertisement
Advertisement